Assessing Abuse Liability Potential Working Group Dinner

Co-Chairs: Mark A. Ammann PharmD, Heddie Martynowicz MS

This session will address clinical and regulatory aspects of abuse liability potential assessment.  The focus will be on (1) Reviewing and providing comments on FDA’s Draft Decision Tree on Assessment of Abuse Potential and (2) Discussing appropriate clinical methodology for assessment of abuse liability potential.